Self-management Program for Greater Trochanteric Pain Syndrome: a Randomized Controlled Trial

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The HIPS-study will be an observer blinded, single-centre, parallel-group randomized controlled trial (RCT). The main purpose of the study is: 1. To investigate the clinical effectiveness of a self- management program versus usual care for patients with greater trochanteric pain syndrome (GTPS). * H0: There is no difference between a self-management program and usual care on pain and function in patients with GTPS. * H1: There is a difference between a self-management program and usual care on pain and function in patients with GTPS. 2. To investigate if self-management is more cost-effective than usual care in the treatment of patients with GTPS. Participants will be randomly allocated into one of two groups: 1) self-management program or 2) usual care. Follow-up will be at 3-, 6- and 12-months.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 70
Healthy Volunteers: f
View:

• Participants between 18 and 70 years of age

• History of lateral hip pain \> 3 months

• Reported average pain intensity the last week ≥ 3 on a numeric rating scale

• Lateral hip pain is the main complaint

• Pain on palpation of the greater trochanter region

• In addition, lateral hip pain on at least one of the following tests:

‣ Single leg stance test: standing 30 seconds on the affected leg

⁃ FADER: passive stretch/compression of gluteus medius/minimus

⁃ FADER-R: static muscle test with resistance to internal hip rotation

⁃ ADD: passive stretch to hip adduction in sidelying

⁃ ADD-R: resisted hip abduction in sidelying

⁃ FABER (Patrick's) test

∙ A positive test is defined as a spontaneous reproduction of the participant's lateral hip pain. In participants with bilateral lateral hip pain, the worst hip will be included, and the presence of bilateral pain will be documented.

Locations
Other Locations
Norway
Oslo University Hospital, Ullevål
RECRUITING
Oslo
Contact Information
Primary
Marianne Bakke Johnsen, PhD
m.b.johnsen@medisin.uio.no
+47 92439663
Time Frame
Start Date: 2024-03-12
Estimated Completion Date: 2027-06-30
Participants
Target number of participants: 110
Treatments
Experimental: Self-management
The intervention will consist of 3-5 individual sessions over 12 weeks with a physiotherapist.~There will be 3 physiotherapists delivering the self-management intervention.
Active_comparator: Usual care
Given standardized information at baseline and free to choose further treatment in primary care.
Related Therapeutic Areas
Sponsors
Collaborators: Fysiofondet, University of Oslo, Oslo Metropolitan University
Leads: Oslo University Hospital

This content was sourced from clinicaltrials.gov